Abstract
Early identification of individuals at risk of dementia will become crucial when effective preventative strategies for this condition are developed. Various dementia prediction models have been proposed, including clinic-based criteria for mild cognitive impairment, and more-broadly constructed algorithms, which synthesize information from known dementia risk factors, such as poor cognition and health. Knowledge of the predictive accuracy of such models will be important if they are to be used in daily clinical practice or to screen the entire older population (individuals aged ≥65 years). This article presents an overview of recent progress in the development of dementia prediction models for use in population screening. In total, 25 articles relating to dementia risk screening met our inclusion criteria for review. Our evaluation of the predictive accuracy of each model shows that most are poor at discriminating at-risk individuals from not-at-risk cases. The best models incorporate diverse sources of information across multiple risk factors. Typically, poor accuracy is associated with single-factor models, long follow-up intervals and the outcome measure of all-cause dementia. A parsimonious and cost-effective consensus model needs to be developed that accurately identifies individuals with a high risk of future dementia.
Key Points
-
Strategies are needed to identify individuals at risk of dementia long before disease onset, so that resources, treatment and prevention efforts can be efficiently targeted
-
Numerous models of dementia risk have been proposed but their relative merits in terms of predictive accuracy are unknown
-
Our evaluation of the literature suggests that current risk models are poor at distinguishing people at risk of developing dementia from not-at-risk individuals
-
A consensus model for the prediction of dementia is needed that is applicable to both population and clinical settings
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Matthews, F. E., Stephan, B. C., Bond, J., McKeith, I. & Brayne, C. Operationalisation of mild cognitive impairment: a graphical approach. PLoS Med. 4, 1615–1619 (2007).
Petersen, R. C. et al. Current concepts in mild cognitive impairment. Arch. Neurol. 58, 1985–1992 (2001).
Levy, R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int. Psychogeriatr. 6, 63–68 (1994).
Winblad, B. et al. Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256, 240–246 (2004).
Mitchell, A. J. & Shiri-Feshki, M. Rate of progression of mild cognitive impairment to dementia—meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119, 252–265 (2009).
Matthews, F. E., Stephan, B. C., McKeith, I. G., Bond, J. & Brayne, C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J. Am. Geriatr. Soc. 56, 1424–1433 (2008).
Farias, S. T., Mungas, D., Reed, B. R., Harvey, D. & DeCarli, C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch. Neurol. 66, 1151–1157 (2009).
Ganguli, M., Dodge, H. H., Shen, C. & DeKosky, S. T. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 63, 115–121 (2004).
Stephan, B. C., Brayne, C., McKeith, I. G., Bond, J. & Matthews, F. E. Mild cognitive impairment in the older population: who is missed and does it matter? Int. J. Geriatr. Psychiatry 23, 863–871 (2008).
Matthews, F. et al. The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS Med. 2, e193 (2005).
Artero, S., Petersen, R., Touchon, J. & Ritchie, K. Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement. Geriatr. Cogn. Disord. 22, 465–470 (2006).
Baars, M. A. et al. Predictive value of mild cognitive impairment for dementia. The influence of case definition and age. Dement. Geriatr. Cogn. Disord. 27, 173–181 (2009).
Busse, A., Bischkopf, J., Riedel-Heller, S. G. & Angermeyer, M. C. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria: results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br. J. Psychiatry 182, 449–454 (2003).
Busse, A., Bischkopf, J., Riedel-Heller, S. G. & Angermeyer, M. C. Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol. Med. 33, 1029–1038 (2003).
Busse, A., Hensel, A., Gühne, U., Angermeyer, M. C. & Riedel-Heller, S. G. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 67, 2176–2185 (2006).
Ritchie, K., Artero, S. & Touchon, J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 56, 37–42 (2001).
Folstein, M. F., Folstein, S. E. & McHugh, P. R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198 (1975).
Busse, A., Bischkopf, J., Riedel-Heller, S. G. & Angermeyer, M. C. Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol. Scand. 108, 71–81 (2003).
Bidzan, L., Pachalska, M. & Bidzan, M. Predictors of clinical outcome in MCI. Med. Sci. Monit. 13, CR398–CR405 (2007).
Palmer, K. et al. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68, 1596–1602 (2007).
Ravaglia, G. et al. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement. Geriatr. Cogn. Disord. 21, 51–58 (2006).
Tabert, M. H. et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 58, 758–764 (2002).
Fleisher, A. S. et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 70, 191–199 (2008).
Hirao, K. et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 28, 1014–1021 (2005).
Kantarci, K. et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 72, 1519–1525 (2009).
McKelvey, R. et al. Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss. Can. J. Neurol. Sci. 26, 23–28 (1999).
Herukka, S. K., Pennanen, C., Soininen, H. & Pirttilä, T. CSF Aβ42, tau and phosphorylated tau correlate with medial temporal lobe atrophy. J. Alzheimers Dis. 14, 51–57 (2008).
Hsiung, G. Y., Sadovnick, A. D. & Feldman, H. Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 171, 863–867 (2004).
Hyman, B. T. et al. Apolipoprotein E and cognitive change in an elderly population. Ann. Neurol. 40, 55–66 (1996).
Mattsson, N. et al. CSF Biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385–393 (2009).
Mitchell, A. J. CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies. J. Neurol. Neurosurg. Psychiatry 80, 966–975 (2009).
Riemenschneider, M. et al. Cerebrospinal fluid tau and β-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch. Neurol. 59, 1729–1734 (2002).
Tang, B. L. & Kumar, R. Biomarkers of mild cognitive impairment and Alzheimer's disease. Ann. Acad. Med. Singapore 37, 406–416 (2008).
Barnes, D. E. et al. Predicting risk of dementia in older adults: the late-life dementia risk index. Neurology 73, 173–179 (2009).
Hensel, A., Angermeyer, M. C. & Riedel-Heller, S. G. Measuring cognitive change in older adults. Do reliable change indices of the SIDAM predict dementia? J. Neurol. 254, 1359–1365 (2007).
Hensel, A. et al. Does a reliable decline in Mini Mental State Examination total score predict dementia? Diagnostic accuracy of two reliable change indices. Dement. Geriatr. Cogn. Disord. 27, 50–58 (2009).
Holtzer, R., Verghese, J., Wang, C., Hall, C. B. & Lipton, R. B. Within-person across-neuropsychological test variability and incident dementia. JAMA 300, 823–830 (2008).
Jorm, A. F., Masaki, K. H., Petrovitch, H., Ross, G. W. & White, L. R. Cognitive deficits 3 to 6 years before dementia onset in a population sample: the Honolulu–Asia aging study. J. Am. Geriatr. Soc. 53, 452–455 (2005).
Jungwirth, S. et al. Screening for Alzheimer's dementia at age 78 with short psychometric instruments. Int. Psychogeriatr. 21, 548–559 (2009).
Masur, D. M., Sliwinski, M., Lipton, R. B., Blau, A. D. & Crystal, H. A. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44, 1427–1432 (1994).
Nakata, E. et al. Combined memory and executive function tests can screen mild cognitive impairment and converters to dementia in a community: the Osaki–Tajiri project. Neuroepidemiology 33, 103–110 (2009).
Nielsen, H., Lolk, A., Andersen, K., Andersen, J. & Kragh-Sørensen, P. Characteristics of elderly who develop Alzheimer's disease during the next two years-a neuropsychological study using CAMCOG. The Odense Study. Int. J. Geriatr. Psychiatry 14, 957–963 (1999).
Rapp, M. A. & Reischies, F. M. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE). Am. J. Geriatr. Psychiatry 13, 134–141 (2005).
Tierney, M. C., Yao, C., Kiss, A. & McDowell, I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64, 1853–1859 (2005).
Kivipelto, M. et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 5, 735–741 (2006).
Mitnitski, A. et al. A vascular risk factor index in relation to mortality and incident dementia. Eur. J. Neurol. 13, 514–521 (2006).
Hogan, D. B. & Ebly, E. M. Predicting who will develop dementia in a cohort of Canadian seniors. Can. J. Neurol. Sci. 27, 18–24 (2000).
Jungwirth, S. et al. Prediction of Alzheimer dementia with short neuropsychological instruments. J. Neural Transm. 116, 1513–1521 (2009).
Palmer, K., Bäckman, L., Winblad, B. & Fratiglioni, L. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ 326, 245 (2003).
Waite, L. M., Broe, G. A., Grayson, D. A. & Creasey, H. Preclinical syndromes predict dementia: the Sydney older persons study. J. Neurol. Neurosurg. Psychiatry 71, 296–302 (2001).
Bäckman, L., Jones, S., Berger, A. K., Laukka, E. J. & Small, B. J. Multiple cognitive deficits during the transition to Alzheimer's disease. J. Intern. Med. 256, 195–204 (2004).
Wechsler, D. Manual for the Wechsler Adult Intelligence Scale—Revised (The Psychological Corporation, New York, 1981).
Barnes, D. E. et al. Commentary on “Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.” Dementia risk indices: a framework for identifying individuals with a high dementia risk. Alzheimers Dement. 6, 138–141 (2010).
Cook, N. R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115, 928–935 (2007).
Cook, N. R. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin. Chem. 54, 17–23 (2008).
Acknowledgements
Désirée Lie, Univesity of California, Orange, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the MedscapeCME-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Studies of mild cognitive impairment models reviewed (DOC 180 kb)
Supplementary Table 2
Studies of non-mild cognitive impairment models reviewed (DOC 464 kb)
Rights and permissions
About this article
Cite this article
Stephan, B., Kurth, T., Matthews, F. et al. Dementia risk prediction in the population: are screening models accurate?. Nat Rev Neurol 6, 318–326 (2010). https://doi.org/10.1038/nrneurol.2010.54
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.54
This article is cited by
-
Multipredictor risk models for predicting individual risk of Alzheimer’s disease
Journal of Translational Medicine (2023)
-
Can Patients with Dementia Be Identified in Primary Care Electronic Medical Records Using Natural Language Processing?
Journal of Healthcare Informatics Research (2023)
-
External validation of existing dementia prediction models on observational health data
BMC Medical Research Methodology (2022)
-
Development and internal validation of a prognostic model for 15-year risk of Alzheimer dementia in primary care patients
Neurological Sciences (2022)
-
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6
Alzheimer's Research & Therapy (2021)